Sunshine Biopharma (SBFM) Receivables (2015 - 2026)
Sunshine Biopharma (SBFM) posted Receivables of $4.04 million for Q2 2026, up 12.5% from $3.59 million a year earlier and up 0.6% from the prior quarter.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Receivables (2015 - 2026) Analysis & Trends
At the end of FY2025, Sunshine Biopharma's Receivables came in at $3.46 million, down 10.6% from FY2024.
- Annual Receivables shows a five-year compound annual growth rate of 348.1% (FY2020 to FY2025).
- In prior years, Sunshine Biopharma's Receivables was $3.87 million in FY2024 (+51.6%), $2.55 million in FY2023 (+33.5%), $1.91 million in FY2022 and $7,798 in FY2021 (+307.0%).
- Quarterly Receivables has run from a low of $22.00 in Q3 2022 to a high of $4.16 million in Q3 2025 over five years.
- On a year-over-year basis, Receivables increased in six of the last eight quarters, with growth averaging 21.2%.
- The strongest year-over-year quarter for Receivables in the past five years was Q4 2021, with growth of 307.0%; the weakest was Q3 2022, with a decline of 98.1%.
- According to Business Quant data, Receivables for the three prior quarters was $4.01 million (Q1 2026), $3.46 million (Q4 2025) and $4.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Sunshine Biopharma | 297,640.62 | -38.79 Mn | 2.43 Mn | 4.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.04 Mn |
| Mar 31, 2026 | 4.01 Mn |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 4.16 Mn |
| Jun 30, 2025 | 3.59 Mn |
| Mar 31, 2025 | 3.45 Mn |
| Dec 31, 2024 | 3.87 Mn |
| Sep 30, 2024 | 3.22 Mn |
| Jun 30, 2024 | 3.97 Mn |
| Mar 31, 2024 | 2.83 Mn |
| Dec 31, 2023 | 2.55 Mn |
| Sep 30, 2023 | 2.03 Mn |
| Jun 30, 2023 | 2.01 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 1.91 Mn |
| Sep 30, 2022 | 22.00 |
| Jun 30, 2022 | 24.00 |
| Mar 31, 2022 | 24.00 |
| Dec 31, 2021 | 7,798.00 |
| Sep 30, 2021 | 1,129.00 |
API Access
Sunshine Biopharma Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();